CD8A and neoplasm: This enhanced persistence and anti-tumour activity is underpinned by metabolic rewiring, with TGR CD8+ effector T cells undergoing a metabolic shift towards OXPHOS and showing an enhanced anabolic phenotype upon re-exposure to glucose.